Uxin Limited announced that Ms. Rong Lu has tendered her resignation from the position as the Company?s director for personal reasons, effective on May 23, 2025. The board has also appointed Ms. Li Ying, currently an independent investor focused on artificial intelligence and consumer sectors, as a new director, effective May 23, 2025. Ms. Rong Lu has served on the board of directors of the Company for over 12 years.
Ms. Li Ying is currently an independent investor focused on artificial intelligence and consumer sectors. She has over 15 years of experience in the international capital markets. Ms. Ying was a partner at Clearvue Partners, a mid-cap venture capital fund from 2012 to 2023, where she led investments in a number of industry-leading companies across the internet, artificial intelligence, and consumer sectors.
Her investment portfolio includes 111 Inc. (Nasdaq: YI), Ping An Healthcare and Technology Company Limited (HKSE: 1833), Pony AI Inc. (Nasdaq: PONY), and Intercos Group (Borsa Italiana: ICOS). Prior to joining Clearvue Partners, Ms. Ying worked in the investment banking division of Goldman Sachs from 2008 to 2012, where she led a number of IPO transactions for Chinese companies in Hong Kong and the United States. Ms. Ying served as a financial performance management consultant at Accenture from 2004 to 2006, and as an auditor at PricewaterhouseCoopers Zhong Tian LLP from 2002 to 2004.
Ms. Ying received her MBA from the Wharton School at the University of Pennsylvania and a bachelor of science degree in Chemistry from Fudan University.
